Endocardial Mapping With the CoreMap EP Mapping System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 245 participants.
Also called NCT06529978
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 245 participants
- Sponsor
- CoreMap Inc.
- Registry
-
NCT06529978
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Czechia
- Registry status
- Recruiting
Technical summary
Registry record NCT06529978. Non-randomized; no masking; primary purpose treatment. Start 2024-07-25 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endocardial Mapping With the CoreMap EP Mapping System
- Acronym
- INvENI
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- CoreMap EP Mapping System Mapping
- Intervention (Device)
- CoreMap EP Mapping System Map-Guided Ablation
- Lead sponsor
- CoreMap Inc.
Record details
- Record id
cardio:ct-nct06529978- Content hash
6226b5dc8c4bdfa375bfda2dc586826edb9485eddd0081a2c16ad7c09c7222d8